The tumor suppressor p53 is commonly inhibited under conditions in which the PI3K/PKB(Akt) pathway is activated. Intracellular levels of p53 are controlled by the E3 ubiquitin ligase Mdm2.
Introduction
The phosphatidylinositide3'-OH kinase (PI3K) 1 -PKB/Akt pathway is a key component of growth factor-induced cell survival. This pathway has been implicated in suppressing apoptosis in a number of cell types in response to a variety of stimuli, including growth factor withdrawal, cellcycle discordance, loss of cell adhesion, DNA damage and treatment with anti-Fas antibody or TGFβ (1) (2) (3) . A number of PKB substrates that are components of the intrinsic cell death machinery have been identified, including glycogen synthase kinase-3, the Bcl2 family member BAD, the protease caspase-9, and Forkhead transcription factors (1) (2) (3) (4) . In each case, phosphorylation of these proteins by PKB suppresses their pro-apoptotic function. Stimulation of cells with survival factors causes activation and nuclear translocation of PKB in target cells (5, 6) , suggesting that PKB may modulate nuclear targets. Several recent studies have shown that p53-mediated apoptosis is inhibited under conditions in which the PI3K/PKB pathway is activated (7) (8) (9) (10) (11) . The p53 gene product is a tumor suppressor that mediates growth arrest, senescence, and apoptosis in response to several cellular stresses (12) . Protein levels of p53 are the most important determinant of its functions. In normal unstressed cells, p53 is an unstable protein with a half-life of less than 20 min, which is kept at very low cellular levels owing to continuous degradation mediated largely by Mdm2 (13) (14) (15) (16) (17) (18) . The Mdm2 was originally identified on double-minute chromosomes of spontaneous transformed mouse 3T3 fibroblasts (19) . Mdm2 harbors a self-and p53-specific E3 ubiquitin ligase activity within its evolutionarily conserved C-terminal RING-finger domain, which mediates p53 ubiquitination and rapid degradation by the 26S proteasome (20, 21) . The current model places p53 and Mdm2 in an autoregulatory feedback loop: Mdm2 transcription is induced by p53, and Mdm2, in turn, binds to the N-terminal transactivation domain of p53, thereby inactivating p53 transcriptional activity (12-14, 17, 18, 20-23) . Low levels of Mdm2 activity induce mono-instructions. Human ∆PH-PKBα cDNA (118-480) was released from pMV1 vector as a EcoRIEcoRI fragment and was inserted into pFastBacHTc vector (Life Technologies Inc.) to generate pFastBacHTc.∆PH-PKBα B. After transposition into the DH10Bac competent cells, the recombinant Bacmid DNA was isolated, and then transfected into Sf9 cells. The resulting recombinant baculovirus particles were used to infect Sf9 cells and the expressed His-tagged ∆PH-PKBα protein was purified on Ni-NTA resin according to the manufacturer's instructions (Qiagen).
Production of antibodies
The peptides: ( polyclonal anti-phosphopeptide antibodies were prepared and affinity-purified using a nonphosphopetide affinity column followed by a phosphopeptide affinity column. These antibodies are referred to as pSer 166 , and pSer
188
. The polyclonal antibody against Mdm2 was raised by immunizing rabbits with GST-Mdm2 (full-length of human Mdm2), and affinity purified using a Cells were grown in DMEM supplemented with 10% fetal calf serum, 100 units/ml of penicillin, and 100 µg/ml of streptomycin. Transfections were performed by calcium phosphate precipitation (5) . Cells were lysed in NP-40 lysis buffer and immunoprecipitated exactly as described (5) . For cell immunofluoresence, the cells were fixed with 3.7% formaldehyde and permeabilized with 0.2% Triton-X 100. After blocking, cells were incubated with monoclonal anti-Mdm2 antibody (SMP14, Santa Cruz Inc., 2 µg/ml diluted in PBS) for 2 hr, followed with polyclonal Mdm2 phospho-antibodies (2 µg/ml diluted in PBS) for additional 2 hr. Cells were then extensively washed, and incubated with FITC-conjugated anti-mouse IgG and TRITC-conjugated anti-rabbit IgG (both 1:100 dilution). After washing, the cells were visualized by Confocal microscopy (Olympus BX61). 
Cell cycle and cell death analysis

In vitro PKB kinase assay
Phosphorylation of Mdm2 and mutants were carried out at 30°C for different times in a final volume of 50 µl of kinase assay buffer containing 50 µg/ml of GST-Mdm2 or mutants and PKB as indicated in each experiment. The reactions were started by addition of 100 µM of [γ-
32
P]ATP and terminated by addition of SDS-sample buffer and immediately boiled for 3 min. Samples were then subjected to 8% SDS-PAGE, followed by autoradiography or 32 P determination in excised gel slices, at positions corresponding to Mdm2. To determine the effect of phosphorylation on Mdm2 self-ubiquitination, phosphorylation of Mdm2 was carried out under the similar conditions using nonradioactive ATP instead of [γ-32 P]ATP. At each time point, the reaction was terminated by addition of 10 mM EDTA (final) and 20 µl of 50% Glutathione Sepharose 4B. After extensively washed, the beads bound GST-Mdm2 was used for ubiquitination assay.
In vitro ubiquitination assay 32 P-labeling of GST-ubiquitin and ubiquitination assay were carried out as described previously (35) . Assay conditions were 30 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 1 mM dithiothreitol, 2 mM ATP, 15 ng of E1 ubiquitin-activating enzyme, 0.5 µg of GST-UbcH5, and 1.5 µg GST-Mdm2 or mutants in a final volume of 50 µl. The reactions were started by the addition of 2 µg 32 P-labeled GST-ubiquitin and incubated at 37°C for 1 hr. GST-Mdm2 was then precipitated by Glutathione Sepharose 4B and eluted in SDS sample buffer. The samples were separated by 8% SDS-PAGE, and then analyzed by autoradiography. Since Mdm2 is capable of self-ubiquitination, and ubiquitin proteasome pathway-dependent degradation is an important mechanism for regulating Mdm2 levels in cells (20, 21) , we asked whether PKB-induced phosphorylation of Mdm2 might have an effect on its ubiquitination. We examined the effect of phosphorylation on reconstituted Mdm2 self-ubiquitination in vitro. As shown in Fig. 1A , Mdm2 self-ubiquitination was observed only in presence of both ubiquitinactivating enzyme E1 and the ubiquitin-conjugating enzyme E2, UbcH5. The degree of Mdm2 selfubiquitination was reduced over time by PKB mediated phosphorylation. To determine which phosphorylation site was responsible for this reduction of Mdm2 self-ubiquitination, two mutants i.e. GST-Mdm2 S166A and GST-Mdm2 S188V (in which the serine residue was individually changed to alanine or valine) were first phosphorylated by recombinant ∆PH-PKBα, and then subjected to the ubiquitination assay. As shown in Fig. 1B , the non-phosphorylated forms of Mdm2 and the mutants were all ubiquitinated in the presence of both E1 and UbcH5. Phosphorylation of wild-type GSTMdm2 completely abolished Mdm2 self-ubiquitination. However, phosphorylation of either GSTMdm2 S166A or GST-Mdm2 S188V only partially inhibited Mdm2 self-ubiquitination. The Mdm2 S188A and Mdm2 S166A/S188V double mutant were highly degraded in E. coli. and could not be tested. Three
Results
Effect of phosphorylation on Mdm2 self-ubiquitination
Asp mutants (GST-Mdm2 S166D , GST-Mdm2
S188D
, and GST-Mdm2 S166D/S188D
) were also generated and tested in this in vitro ubiquitination assay. As shown in Fig. 1C , all three Asp mutants were poorly ubiquitinated, further supporting the idea that the protective effect of PKB on Mdm2 selfubiquitination may be due primarily to the phosphorylation of Mdm2 at Ser 166 and Ser
188
.
Production and characterization of Mdm2 phospho-specific antibodies
To monitor the phosphorylation of Mdm2 in vivo, two rabbit polyclonal antibodies that recognized Mdm2 and GST-Mdm2 S188V phosphorylated by ∆PH-PKBα, but did not detect GST-Mdm2 S166A ( Fig. 2A) . Similarly, pSer 188 could also detect GST-Mdm2 and GST-Mdm2 S166A but not GSTMdm2 S188V when phosphorylated by ∆PH-PKBα. These results suggest that each phospho-antibody specifically detected phosphorylation of Mdm2 by PKB at Ser 166 and Ser
188
, respectively.
IGF-1 induces in vivo phosphorylation of Mdm2 at Ser 166 and Ser 188
To determine whether our phospho-antibodies could detect Mdm2 phosphorylation in vivo, the effect of insulin-like growth factor-1 (IGF-1) on HEK293 cells was examined. Serum-starved cells were incubated with 100 ng/ml IGF-1 for different times, and cell lysates were analyzed by immunoblotting using pSer 166 
PKB promotes Mdm2 phosphorylation in vivo and prevents its degradation
To test whether Mdm2 is phosphorylated in transfected cells, a pEGFP-Mdm2 was co-transfected confirm the activation status of PKB. These data suggested that transfected GFP-Mdm2 is a labile protein that is a target for degradation (20, 21) , and furthermore that PKB phosphorylation is required for protecting Mdm2 from proteasome-dependent destruction, thus increasing Mdm2 stability.
To further confirm the hypothesis that PKB activity is sufficient to stabilize Mdm2, GFP-Mdm2 To investigate whether phosphorylation of Mdm2 by PKB was sufficient to increase its stability, three Ser to Asp phosphorylation site mutants of Mdm2 were constructed and transfected into COS-1 cells. As shown in Fig. 3C , wild-type GFP-Mdm2 (WT) was rapidly degraded in the absence of To examine if Mdm2 ubiquitination is regulated by PKB in vivo, a HA-ubiquitin construct was cotransfected with wild-type GFP-Mdm2 and its mutant in HEK293 cells. As shown in Fig. 3D , ubiquitination of Mdm2 accumulated in wild-type GFP-Mdm2 and HA-ubiquitin co-transfected HEK293 cells, but was significantly reduced in GFP-Mdm2 S166D/S188D and HA-ubiquitin transfected cells. These data further support that PKB-mediated Mdm2 phosphorylation prevents Mdm2 from self-ubiquitination.
Inhibition of the PI3Kinase pathway induces proteasome-dependent degradation of Mdm2
The above results suggest that PKB-mediated phosphorylation might be involved in stabilizing 
Cells lacking PKBα display decreased Mdm2 protein levels and increased susceptibility to UVinduced apoptosis
To confirm the role of PKB in stabilizing Mdm2 in vivo, we examined the level of Mdm2 protein in (38) , and the lack of PKBα in MEFs caused a decrease in Mdm2 protein levels, this suggest that PKB activity was required to stabilize Mdm2 in MEFs. As Mdm2 is a key determinant of p53 stability, we next examined the p53 protein level in these cells. As shown in Fig. 5B , levels of p53
were significantly elevated in Pkbα -/-MEFs. Concomitant with the increase in p53, the expression level of p21
Cip1
in Pkbα -/-MEFs was also increased as compared to control wild-type cells (Fig.   5B ).
Since p53 and its transcriptional target p21 Cip1 play an important role in controlling the G1 and G2/M cell cycle checkpoints that mediate growth arrest and apoptosis (39-41), we next analyzed the cell cycle of MEFs in response to UV-irradiation. As shown in Fig. 5C , the exponentially growing Pkbα -/-MEFs displayed a small but significant increase in the G2/M cell population as compared to their wild-type counterparts. These results correspond well with recent findings by Kandel et al. (42) , who reported on attenuated transition from G2/M to G1 in Pkbα -/-MEFs. Upon treatment with UV-C radiation, a large proportion (up to 60%) of the wild-type MEFs were arrested in G1 phase of cell cycle for the whole period of examination. In contrast, the Pkbα -/-cells displayed only a compromised (50%) and temporary G1 arrest accompanied by a partial G2/M block. Importantly, the majority of Pkbα -/-MEFs underwent apoptotic cell death in the course of experiment, which was manifested by a continuous increase of cell population with sub-G1 DNA content (Fig. 5C ). Since most of the wild-type cells resisted the treatment with UV radiation, these results imply that PKBα protects cells against the UV-induced apoptotic cell death. This is consistent with observations that the knockout of PKBα/Akt1) sensitizes cells to apoptosis after a variety of stimuli (38) . Although the molecular basis for these phenomena is not yet entirely elucidated, it is conceivable that the increased p53 level in the Pkbα -/-knockout MEFs can, at least in part, account for the G2/M delay, compromised G1 arrest, and the elevated apoptosis rate after UV treatment in these cells.
Activation of PKB correlates with Mdm2 phosphorylation in human tumor cell lines
Elevated PKB activity via amplification of PI3K and PKB genes, mutational loss of PTEN or activation of oncogenic receptor tyrosine kinase is a common feature of many human cancers (1, 4, 43 (Fig. 6B and 6C ). In addition, the subcellular localization of endogenous Mdm2 was observed mainly in the nucleus in both cell lines ( Fig. 6B and 6C ), arguing that the nuclear localization of Mdm2 might be independent on the Mdm2 phosphorylation status. These data suggest that activation of PKB leads to the phosphorylation of Mdm2 and plays an essential role in regulating Mdm2 stability in human tumor cells.
Discussion
Growth factor-mediated activation of PI3K/PKB is a key element of cellular survival and proliferation. Activation of PI3K/PKB signaling is thought to be required for the inhibition of p53-dependent apoptosis (7-11), but the exact mechanism for this effect has remained elusive. The stoichiometric balance between the tumor suppresser p53 and its negative regulator Mdm2 may determine the extent of cellular p53 activity and its functions. Levels and activity of both Mdm2 and p53 are regulated by posttranslational modifications and protein-protein interaction in cells.
The stability of p53 can be regulated by phosphorylation at multiple sites (13, 14) . Similarly, (48) . Phosphorylation at these sites results in the inhibition of Mdm2-p53 complex formation, thereby increasing p53 stability. Mdm2 could be ) in response to ionizing irradiation, which contributes to p53 stabilization (51) . More recent data showed that Mdm2 destabilization requires the activity of DNA-damage-dependent PI 3-kinase family members, most likely through Mdm2 phosphorylation on multiple sites (52) . It has also been demonstrated that the stability of Mdm2 can be modulated via association of Mdm2 with p53 or p19/p14 ARF or MdmX (27, 28 ), but not in Xenopus (13, 14) . A tentative model for regulation of Mdm2-p53 pathway by PKB is shown in Fig. 7 . Our model proposes that PKB-mediated phosphorylation of Mdm2 may be a central event in negatively regulating p53 function under conditions where the PI3K/PKB signaling is activated. However, how phosphorylation by PKB affects the Mdm2 self-ubiquitination still remains to be elucidated.
Since the ubiquitin-conjugating site on Mdm2 is located at the C-terminal RING finger domain (61) , it is difficult to envision a reduction of Mdm2 self-ubiquitination via direct steric hindrance resulting from phosphorylation in the N-terminal half of the molecule. Nevertheless, it is possible that phosphorylation could induce a conformation change in Mdm2 that may efficiently block the ubiquitin conjugating site(s) at the C-terminal RING finger domain, which would, in turn, protect
Mdm2 from degradation
The PKB phosphorylation sites on Mdm2 identified in our study lie in the vicinity of the nuclear localization sequence (NLS, residues 181-185) and nuclear export sequence (NES, residues 191-202) domain, which regulates Mdm2 nuclear import and export, raising the possibility of a functional connection between Mdm2 phosphorylation and nuclear translocation. Indeed, phosphorylation of Mdm2 by PKB was reported to result in Mdm2 nuclear translocation (31, 32) leading to a reduction in p53 transactivation (31) and enhancement of Mdm2-mediated ubiquitination of p53 (32) . It is possible that the subcellular relocalization of Mdm2 might also impair Mdm2 self-ubiquitination and increase the stability of Mdm2 protein, but this model has yet to be tested experimentally. However, it should be pointed out that both endogenous Mdm2 ( Fig.   5A and Fig. 6B , C) and transfected Mdm2 (31, 51, 60) were exclusively located in the nucleus independent of phosphorylation status of Mdm2. We and other groups (58) (A) GST-Mdm2 (50 µg/ml) was phosphorylated by recombinant ∆PH-PKBα for the indicated times. Both phosphorylated and unphosphorylated GST-Mdm2 was subjected to a selfubiquitination assay using 32 P-GST-ubiquitin as described in "Experimental Procedures". The gel was then stained with Coomassie blue followed by autoradiography.
(B and C) GST-Mdm2 wild-type (WT) and various mutants (GST-Mdm2 S166A , S166A; GSTMdm2 S188V , S188V; GST-Mdm2 S166D , S166D; GST-Mdm2 S188D , S188D; GST-Mdm2
, D D) were phosphorylated in the presence (+) or absence (-) of ∆PH-PKBα for 2 hr and subjected to the Mdm2 self-ubiquitination assay as described above. 
